SAN DIEGO, May 13 /PRNewswire-FirstCall/ -- CareFusion Corporation, the company that will become public from the planned spinoff of Cardinal Health's clinical and medical products businesses, today announced that Edward J. Borkowski has been named chief financial officer (CFO).
Borkowski, 49, has been CFO of Mylan, Inc. since 2002 where he helped transform the company from a U.S.-based generic business to one of the largest generic pharmaceutical companies in the world, operating in more than 60 countries. During his tenure at Mylan, the company grew revenue from $900 million to more than $4.5 billion through the combination of organic growth and acquisition, including a $7 billion acquisition of Merck Generics in 2007. Borkowski also played a key role in Mylan's acquisition of Matrix Laboratories in 2006, the largest acquisition in India's pharmaceutical sector at the time. He will start with CareFusion on May 26.
"Ed has a proven record of identifying growth opportunities and executing against them with very positive results for shareholders," said David Schlotterbeck, chief executive officer of CareFusion. "He will be a key contributor to our management team as we execute our strategies for growth."
Prior to Mylan, Borkowski was vice president of global finance and information technology of consumer health care at Pharmacia Corporation. Through his various leadership positions with Mylan, Pharmacia and American Home Products Corporation, Borkowski has gained broad knowledge of the health care industry, with deep experience in corporate finance, treasury, tax, business development, information technology and operations. He earned his Bachelor of Science degree in economics and political science from
Cardinal Health's target is to complete the planned spinoff later this summer. Completion and specific timin
|SOURCE CareFusion Corporation|
Copyright©2009 PR Newswire.
All rights reserved